Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

Autor: Look M, van Putten W, Duffy M, Harbeck N, Ij, Christensen, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Cg, Fred Sweep, Ulm K, Jp, Peyrat, Pm, Martin, Magdelenat H, Brünner N, Catherine Duggan, Bw, Lisboa, Po, Bendahl, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder M, Manders P, Edward Fiets W, Blankenstein M, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex L, Klijn J, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens J, Po, Bendah

Publikováno v: Thrombosis and Haemostasis, 90, 538-48
Thrombosis and Haemostasis, 90, 538-548. Georg Thieme Verlag
Europe PubMed Central
Thrombosis and Haemostasis, 90, 3, pp. 538-48
Scopus-Elsevier

Item does not contain fulltext In this report we present an extension of the pooled analysis of the prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I in breast cancer patients. We analyzed a different endpoint, m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c930058ef1b9e1daab6d7e59894e29
https://doi.org/10.1160/th02-11-0264